$AIM ImmunoTech (AIM.US)$ AIM ImmunoTech Announces NYSE American Acceptance of Plan to Regain Listing Compliance Wednesday, 26th February at 1:20 pm OCALA, Fla., Feb. 26, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE: AIM) ("AIM" or the "Company") today announced that it received notice from the NYSE American (the "American") that the American has accepted the Company's Plan to regain compliance with the minimum stockholders' equity requirements of Sections 1003(a)(ii) and 1003(a)(iii) o...
Despite a mid-day price climb, the market capitulated and fell in the afternoon. Investors are awaiting the heaviest of heavy hitter earnings this Wednesday and will not be distracted by $500B in pledged Apple funds from worries that AI is getting pricey. Just past 4 pm ET the$S&P 500 Index (.SPX.US)$traded fell 0.50%, the$Dow Jones Industrial Average (.DJI.US)$climbed 0.08%, and the$Nasdaq Composite Index (.IXIC.US)$...
How Canopy Growth's German Market Entry Could Reshape European Medical Cannabis Landscape
AIM ImmunoTech Announces NYSE American Acceptance of Plan to Regain Listing Compliance
Wednesday, 26th February at 1:20 pm
OCALA, Fla., Feb. 26, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE: AIM) ("AIM" or the "Company") today announced that it received notice from the NYSE American (the "American") that the American has accepted the Company's Plan to regain compliance with the minimum stockholders' equity requirements of Sections 1003(a)(ii) and 1003(a)(iii) o...
👀
Can Teva's Injectable UZEDY Revolutionize Bipolar I Disorder Treatment? FDA Now Reviewing
Just past 4 pm ET the $S&P 500 Index (.SPX.US)$ traded fell 0.50%, the $Dow Jones Industrial Average (.DJI.US)$ climbed 0.08%, and the $Nasdaq Composite Index (.IXIC.US)$...
No comment yet